Medical Device News Magazine

TE Connectivity Opens 1st Global Medical Device Prototyping Center

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

TE Connectivity Corporation, a world leader in connectors and sensors, has opened its global Propelus Prototype Center for medical devices at its existing manufacturing site in Galway, Ireland.

The $5 million rapid prototyping center directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices.

With more than 120 patients treated every minute with a medical device containing TE Connectivity technology, TE’s Galway site fulfills close to the complete global demand for minimally invasive catheter metal shafts, such as coronary stents used to open clogged heart arteries and neurovascular coils which are used in the treatment of brain aneurysms.

The Propelus Prototype Center features advanced engineering capabilities, including build-to-print services, quick turnaround prototype production and 3D printing. TE engineers work alongside customers to quickly make customer concepts a reality, enabling them to visit and leave with a physical, functional prototype, along with a detailed commercialization proposal. TE Connectivity can also manufacture the customer’s final device at high volumes in one of TE’s global manufacturing facilities and help manage their supply chain.

Commenting on the launch of the Propelus Prototype Center, Director of Operations Mark Gill said: “The principle is simple – getting high quality prototypes into customers’ hands as quickly as possible. By improving the speed of product development and manufacturing, TE will help customers innovate and iterate advanced treatments at a more efficient pace, ultimately transforming patient care for the better.”

“When our Propelus Prototype Center engineers are not busy working on customer projects, they are innovating for the future, staying close to new therapies, and trialing new technologies so we stay ahead of the curve, today and tomorrow.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”